Maziar Mike Doustdar appointed President and CEO of Novo Nordisk
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
The company would be commissioning 3 hubs in Q2 FY26 across our Core Geography and West Bengal
The company reported consolidated EBITDA loss of Rs. 10.5 crore in Q1 FY26 as compared to loss of Rs. 45.3 crore in the same period last year
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
Aman holds a bachelor’s degree in economics from Boston University and an MBA from Columbia University, New York
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Kushwaha previously served as Chief Digital & Information Officer at Jubilant Ingrevia Limited
This achievement is part of the population-based initiative for screening, prevention, and management of Non-Communicable Diseases
GSK and Hengrui Pharma enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology
Subscribe To Our Newsletter & Stay Updated